Propanc Biopharma, Inc. (Nasdaq: PPCB) ("Propanc" or the "Company"), a biopharmaceutical company focused on developing novel treatments for chronic ...

Novartis (NVS) and Ionis Pharmaceuticals' (IONS) high-profile Lp(a) flop on Friday reverberated through biotech stocks on ...

Almost as many biotechs have opted for a reverse merger to reach the public markets as those executing more traditional ...

Not only is the XBI continuing to hover around a historic high, but drug companies can’t seem to get enough of both large IPOs and big-ticket M&A.

Redhill Biopharma Ltd. RDHL shares are up on Monday as investors react to the company’s divestment of Talicia and the ...

As geopolitical tensions between the U.S. and China grow increasingly complicated, here are five alternative territories for ...

Baxter International, a global healthcare products company with more than $15 billion in annual revenue, kicked off 2023 with the new year’s resolution of becoming streamlined and nimble. Five months ...

Citigroup's Biopharma Back to School Summit 2026 September 9, 2026 8:00 AM EDTCompany ParticipantsJay Duker - President, CEO ...

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one ...

Open-label, two-part dose-escalation and dose-expansion study planned in up to 50 patients with advanced solid tumors across AustraliaMELBOURNE, Australia, Sept. 09, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: ...